
In a new podcast episode, Thomas Hope, MD, shares his insights on glioma imaging and the potential impact of the recently FDA-approved PET agent floretyrosine (18F-FET),
Case History: 47-year-old male with headaches followed by generalized tonic-clonic convulsions.
Case History: 47-year-old male presented with complaints of headaches followed by episode of generalized tonic-clonic convulsions.




